(1,3)-β-D-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: a randomized trial.
De Pascale G, Posteraro B, D'Arrigo S, Spinazzola G, Gaspari R, Bello G, Montini LM, Cutuli SL, Grieco DL, Di Gravio V, De Angelis G, Torelli R, De Carolis E, Tumbarello M, Sanguinetti M, Antonelli M.
De Pascale G, et al. Among authors: gaspari r.
Crit Care. 2020 Sep 5;24(1):550. doi: 10.1186/s13054-020-03265-y.
Crit Care. 2020.
PMID: 32891170
Free PMC article.
Clinical Trial.